Focus

Rare Disease Investors: Angels and VC Firms

The RaiseHunt database lists 91 Rare Disease investors: 17 angel investors and 74 people at 30 firms. Most list Series A and Seed among their stages; the largest hubs are New York, Boston and Paris.

Strongest in New York, Boston and Paris

Common stages: Series A and Seed

91
Rare Disease investors
17
Angel investors
74
People at VC/PE firms
30
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

91 Rare Disease investors

Showing 81-91

Filters
NH
Noelle Hutchins

Principal

Boston, United States
Private equityVenture capital
Healthcare
View profile
VO
Vincent Ossipow

Partner

Geneva, Switzerland
Private equityVenture capital
Healthcare
View profile
SM
Shailesh Maingi

Managing Partner

Raleigh, United States
Venture capital
AIHealthcare
View profile
RL
Richard Lipkin

Founder

New York City, United States
Venture capital
AIHardware
View profile
CI
Chieze Ibeneche-Nnewihe

angel investor

Boston, United States
Angel
Healthcare
View profile
AP
Arnaud Pradier

Venture Partner

Malakoff, France
Venture capital
AIHealthcare
View profile
BJ
Brent Jiang

Vice President

Boston, United States
Private equityVenture capital
Healthcare
View profile
CN
Claudio Nessi

Managing Director

Geneva, Switzerland
Private equityVenture capital
Healthcare
View profile
RW
Robert Wolk

Managing Partner

New York, United States
Venture capital
AIHealthcare
View profile
RB
Roshawn Blunt

Venture Partner

San Diego, United States
Private equityVenture capital
Healthcare
View profile
PT
Po Ting Liu

Associate

Brookline, United States
Private equity
Healthcare
View profile

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal